Filing Details

Accession Number:
0001104659-16-139269
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-12 13:01:53
Reporting Period:
2016-08-10
Filing Date:
2016-08-12
Accepted Time:
2016-08-12 13:01:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638287 Gemphire Therapeutics Inc. GEMP Pharmaceutical Preparations (2834) 472389984
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674006 Mina Sooch 43334 Seven Mile Road
Suite 1000
Northville MI 48167
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-10 11,078 $0.00 11,078 No 4 C Indirect Held by the Arvinder S. Sooch Trust
Common Stock Acquisiton 2016-08-10 1,212 $6.71 12,290 No 4 J Indirect Held by the Arvinder S. Sooch Trust
Common Stock Acquisiton 2016-08-10 27,141 $6.71 39,431 No 4 C Indirect Held by the Arvinder S. Sooch Trust
Common Stock Acquisiton 2016-08-10 52,500 $10.00 693,732 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Held by the Arvinder S. Sooch Trust
No 4 J Indirect Held by the Arvinder S. Sooch Trust
No 4 C Indirect Held by the Arvinder S. Sooch Trust
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2016-08-10 11,078 $0.00 11,078 $0.00
Common Stock 8% Convertible Subordinated Promissory Notes Disposition 2016-08-10 0 $0.00 27,141 $6.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date.
  2. Arvinder Sooch is the reporting person's husband. These shares are indirectly owned by him as trustee of the Arvinder S. Sooch Trust.
  3. Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock.
  4. The notes were issued in the original principal amount of $175,000. The outstanding principal and $7,015 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.